Regulatory Focus™ > News Articles > Anvisa Unveils New Adverse Event Database

Anvisa Unveils New Adverse Event Database

Posted 09 December 2013 | By Louise Zornoza 

Brazil's national regulatory agency, Anvisa, has unveiled a new database that will gather information on adverse events relating to blood products, tissues, cells and organs. 

The database, which was developed by Italy's National Transplant Center, already includes more than 900 adverse event reports related to cell therapies, organ donations, and assisted reproduction, among others. 

The database was first unveiled at the World Health Organization's (WHO) Third Global Meeting on Biomonitoring held in Brazil from December 7 to 9, which brought together an international group of health authorities, regulators, members of national centers on disease control and epidemiology, scientific associations, and Medical Products of Human Origin (MPHO) professionals. 


Read all Breaking News from RegLink


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe